Product image of Glyclada (Gliclazide) supplied by GNH India

Glyclada

Active Ingredient:
Gliclazide
Origin:
EU

Glyclada (Gliclazide)

Glyclada is a prescription oral medication that contains the active ingredient gliclazide, a second‑generation sulfonylurea, formulated for the treatment of type 2 diabetes mellitus. It is marketed in the European Union and is taken by mouth. The product’s strength and dosage form are not specified in the available data, and it is supplied only with a physician’s prescription.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glyclada is indicated for the management of blood glucose levels in adults with type 2 diabetes mellitus, typically when diet, exercise, and other oral agents are insufficient.

  • Improves glycemic control by stimulating insulin release from pancreatic β‑cells.
  • Used as monotherapy in patients newly diagnosed with type 2 diabetes.
  • Can be combined with metformin or other oral antidiabetic agents when additional glucose lowering is needed.
  • May be prescribed when other sulfonylureas are not tolerated.
  • Intended for chronic use as part of a comprehensive diabetes management plan.

Side Effects

The safety profile of Glyclada reflects the typical effects observed with sulfonylurea agents, ranging from mild, frequently reported events to rare but serious reactions.

Common

  • Low blood sugar (hypoglycemia)
  • Nausea or abdominal discomfort
  • Headache
  • Dizziness

Serious

  • Severe allergic reaction such as skin rash or swelling
  • Persistent hypoglycemia leading to loss of consciousness

Precautions & Warnings

Before starting Glyclada, healthcare providers assess several clinical factors to minimize risks and ensure appropriate use.

  • Verify diagnosis of type 2 diabetes and assess renal and hepatic function.
  • Use caution in elderly patients due to increased susceptibility to hypoglycemia.
  • Avoid use in patients with known sulfonylurea hypersensitivity.
  • Monitor blood glucose regularly, especially during dose adjustments.
  • Counsel patients on recognizing and managing hypoglycemia symptoms.

Avoid Interactions

Glyclada may interact with other medicines, affecting its glucose‑lowering effect or increasing the risk of adverse events.

Avoid

  • Concurrent use with other sulfonylureas or insulin, which can cause severe hypoglycemia.
  • Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that may raise gliclazide plasma levels.
  • MAO‑B inhibitors, which can potentiate hypoglycemic effects.

Use with caution

  • Co‑administration with beta‑blockers may mask hypoglycemia symptoms.
  • Combination with thiazide diuretics may require closer glucose monitoring.

Frequently Asked Questions

Glyclada contains gliclazide, which stimulates insulin secretion from pancreatic β‑cells by closing ATP‑sensitive potassium channels, causing cell depolarization and calcium influx that triggers insulin release.

By increasing endogenous insulin release, Glyclada lowers fasting and post‑prandial glucose levels, supporting overall glycemic control when combined with diet and exercise.

Common adverse effects include hypoglycemia, nausea or abdominal discomfort, headache, and dizziness. These are generally mild and reversible.

If symptoms such as confusion, loss of consciousness, seizures, or prolonged weakness occur, immediate medical evaluation is recommended.

Yes, Glyclada is often combined with metformin to achieve additional glucose‑lowering effect, provided the combination is prescribed and monitored by a healthcare professional.

Elderly patients may be more sensitive to hypoglycemia; dose adjustments and close monitoring are advised when prescribing Glyclada to this population.

Reduced renal function can increase gliclazide exposure; clinicians may need to lower the dose or select an alternative therapy based on the severity of impairment.

Patients should limit excessive alcohol intake and maintain consistent carbohydrate intake to reduce the risk of unpredictable blood‑sugar fluctuations.

Glyclada is generally not recommended during pregnancy or lactation unless the benefits outweigh the risks; a healthcare provider should evaluate each case individually.

Regular self‑monitoring of blood glucose is advised, especially after dose changes, during illness, or when symptoms of hypoglycemia appear.

If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose; do not double‑dose.

Some OTC drugs, such as certain antihistamines, NSAIDs, or herbal supplements, may affect blood sugar or interact with gliclazide; patients should consult their pharmacist or physician before adding new OTC products.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Gliclazide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT